Patterns of complementary and alternative medicine (CAM) use in patients with inflammatory bowel disease: Perceived stress is a potential indicator for CAM use

Complementary Therapies in Medicine

Volumn 15, Issue 1, 2007, Pages 30-37

  Langhorst, Jost ^a   Anthonisen, Inga B ^a   Steder Neukamm, Ulf ^b   Luedtke, Rainer ^c   Spahn, Guenther ^a   Michalsen, Andreas ^a   Dobos, Gustav J ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b German Crohn's and Ulcerative Colitis Association DCCV eV   (Germany)

^c Karl und Veronica Carstens Stiftung   (Germany)

Author keywords

CAM; Complementary and alternative medicine; Crohn's disease; IBD; Stress perception; Ulcerative colitis

Indexed keywords

BOSWELLIA SERRATA EXTRACT; HERBACEOUS AGENT;

ACUPUNCTURE; ADULT; ALTERNATIVE MEDICINE; ARTICLE; AYURVEDA; CHINESE MEDICINE; CONTROLLED STUDY; CROHN DISEASE; DEMOGRAPHY; DIET THERAPY; DISEASE DURATION; ENTERITIS; FEMALE; GERMANY; HOLISTIC CARE; HOMEOPATHY; HUMAN; MAJOR CLINICAL STUDY; MALE; PHYSIOTHERAPY; PHYTOTHERAPY; QUESTIONNAIRE; REMISSION; SELF CONCEPT; SELF REPORT; SOCIAL ASPECT; STRESS; TREATMENT FAILURE; ULCERATIVE COLITIS;

COLITIS, ULCERATIVE; COMPLEMENTARY THERAPIES; CROHN DISEASE; FEMALE; HEALTH BEHAVIOR; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HOLISTIC HEALTH; HUMANS; MALE; MIDDLE AGED; RELAXATION TECHNIQUES; SOCIOECONOMIC FACTORS; STRESS, PSYCHOLOGICAL;

EID: 33847657575     PISSN: 09652299     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ctim.2006.03.008     Document Type: Article

References (25)

1. Moody G.A., Eaden J.A., Bhakta P., et al. The role of complementary medicine in European and Asian patients with inflammatory bowel disease. Pub Health 112 (1998) 269-271
2. Hilsden R.J., Scott C.M., and Verhoef M.J. Complementary medicine use by patients with inflammatory bowel disease. Am J Gastroenterol 5 (1998) 697-701
3. Rawsthorne P., Shanahan F., Cronin N.C., et al. An international survey of the use and attitudes regarding alternative medicine by patients with inflammatory bowel disease. Am J Gastroenterol 94 (1999) 1298-1303 [2a]
4. Hilsden R.J., Verhoef M.F., Best A., et al. Complementary and alternative medicine use by Canadian patients with inflammatory bowel disease: results from a national survey. Am J Gastroenterol 98 (2003) 1564-1568
5. Zollmann C., and Vickers A. ABC of complementary medicine. Users and practitioners of complementary medicine. Br Med J 319 (1999) 836-838
6. Langhorst J., Anthonisen I.B., Steder-Neukamm U., et al. Amount of systemic steroid medication is a strong predictor for the use of complementary and alternative medicine in German patients with inflammatory bowel disease: results from a national survey. Inflamm Bowel Dis 11 (2005) 287-295
7. Boon H., and Verhoef M.J. Complementary and alternative medicine: a Canadian perspective. In: Ernst E. (Ed). The desktop guide to complementary and alternative medicine, an evidence-based approach (2001), Mosby, Edinburgh/London/New York/Philadelphia/St Louis/Sydney/Toronto 362-373
8. Eisenberg D. Complementary and alternative medicine use in the United States: epidemiology and trends 1990-2000. In: Ernst E. (Ed). The desktop guide to complementary and alternative medicine, an evidence-based approach (2001), Mosby, Edinburgh/London/New York/Philadelphia/St Louis/Sydney/Toronto 374-387
9. Pittler M.H. Complementary and alternative medicine: a european perspective. In: Ernst E. (Ed). The desktop guide to complementary and alternative medicine, an evidence-based approach (2001), Mosby, Edinburgh/London/New York/Philadelphia/St Louis/Sydney/Toronto 388-394
10. Langmead L., Chitnis M., and Rampton D.S. Use of complementary therapies by patients with IBD may indicate psychosocial stress. Inflamm Bowel Dis 3 (2002) 174-179
11. Furnham A. Why do people choose and use complementary therapies?. In: Ernst E. (Ed). Complementary medicine: an objective appraisal (1996), Butterworth Heinemann, Oxford
12. Marstedt G., and Moebus S. Gesundheitsberichterstattung des Bundes Heft 9: Inanspruchnahme alternativer Methoden in der Medizin (2002), Robert Koch Institut
13. Burstein H.J., Gelber S., Guadagnoli E., et al. Use of alternative medicine by women with early-stage breast cancer. N Eng J Med 340 (1999) 1733-1739
14. Verhoef M.J., Hagen N., Pelletier G., et al. Alternative medicine use in neurologic diseases: use in brain tumor patients. Neurology 52 (1999) 617-622
15. Eisenberg D.M., Davis R.B., Ettner S.L., et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow up national survey. JAMA 280 (1998) 1569-1575
16. Angell M., and Kassirer J.P. Alternative medicine-the risks of untested and unregulated remedies. N Engl J Med 339 (1998) 839-841
17. Levenstein S., Prantera C., Varvo V., et al. Stress and exacerbation in ulcerative colitis: a prospective study of patients enrolled in remission. Am J Gastroenterol 9 (2000) 1213-1220
18. Tocchi A., Lepre L., Liotta G., et al. Familial and psychological risk factors of ulcerative colitis. Ital J Gastroenterol Hepatol 29 (1997) 395-398
19. Levenstein S., Prantera C., Varvo V., et al. Psychological stress and disease activity in ulcerative colitis: a multidimensional cross-sectional study. Am J Gastroenterol 89 (1994) 1219-1225
20. Duffy L.C., Zielezny M.A., Marshall J.R., et al. Relevance of major stress events as an indicator of disease activity prevalence in inflammatory bowel disease. Behav Med 17 (1991) 101-110
21. Farhadi A., Keshavarzian A., Van der Kar L.D., et al. Heightened responses to stressors in patients with inflammatory bowel disease. Am J Gastroenterol 100 (2005) 1796-1804
22. Oviedo J., and Farraye F.A. Self-care for the inflammatory bowel disease patient: what can the professional recommend?. Semin. Gastrointest Dis 4 (2001) 223-236
23. Milne B., Joachim G., and Niedhardt J. A stress management programme for inflammatory bowel disease patients. J Adv Nurs 11 (1986) 561-567
24. von Wietersheim J., Overbeck A., Kiel K., Kohler T., Jantschek G., and Feiereis H. The significance of recurrence-inducing events for patients with inflammatory bowel diseases. Results of a prospective longitudinal study over three years. Psychosom Med Psychol 2 (1994) 58-64
25. Elsenbruch S., Langhorst J., Popkirowa K., et al. Effects of mind-body therapy on quality-of-life and neuroendocrine and cellular immune functions in patients with ulcerative colitis. Psychother Psychosom 74 (2005) 277-287